|
Fabhalta - kõvakapsel (200mg)
|
iptakopaan |
L04AJ08 |
Novartis Europharm Limited |
|
Fablyn
|
lasofoxifene tartrate |
G03 |
Dr. Friedrich Eberth Arzneimittel GmbH
|
|
Fabrazyme
|
beetaagalsidaas |
A16AB04 |
Sanofi B.V. |
|
Factor vii baxalta - inj lahuse pulber ja lahusti 600rü 10 ml lahustit n1
|
Human coagulation factor VII |
B02BD05 |
Baxalta Innovations GmbH |
|
Factor vii baxalta - süstelahuse pulber ja lahusti (600rü)
|
VII hüübimisfaktor |
B02BD05 |
Baxalta Innovations GmbH |
|
Factor vii baxalta - süstelahuse pulber ja lahusti (600tü)
|
VII hüübimisfaktor |
B02BD05 |
Baxalta Innovations GmbH |
|
Factor vii baxter 600 iu - inj lahuse pulber ja lahusti 600tü 10 ml lahustit n1
|
Human coagulation factor VII |
B02BD05 |
Baxter AG |
|
Falakef 1000 mg - õhukese polümeerikattega tablett (1000mg)
|
tsefaleksiin |
QJ01DB01 |
I.C.F SRL Industria Chimica Fine |
|
Falakef 500 mg - õhukese polümeerikattega tablett (500mg)
|
tsefaleksiin |
QJ01DB01 |
I.C.F SRL Industria Chimica Fine |
|
Famosan
|
– |
– |
– |
|
Fampridine accord - toimeainet prolongeeritult vabastav tablett (10mg)
|
fampridiin |
N07XX07 |
Accord Healthcare S.L.U. |
|
Fampyra
|
fampridine |
N07XX07 |
Merz Therapeutics GmbH |
|
Famvir
|
– |
– |
– |
|
Fanizan
|
– |
– |
– |
|
Fareston
|
toremifene |
L02BA02 |
Orion Corporation |
|
Faringodol forte - loseng (150mg)
|
koliinsalitsülaat |
A01AD82 |
Richard Bittner AG |
|
Farlutal - tablett (500mg)
|
medroksüprogesteroon |
L02AB02 |
Pfizer Europe MA EEIG |
|
Farmorubicin pfs - inj 2mg / 1ml 5ml n1; 25ml n1
|
Epirubicin |
L01DB03 |
Pfizer Enterprises SARL |
|
Farmorubicin rapid dissolution 10mg
|
– |
– |
– |
|
Farpenta
|
olansapiin |
N05AH03 |
Sanoswiss UAB |
|
Farydak
|
panobinostaat |
L01XH03 |
pharmaand GmbH |
|
Fasenra
|
benralizumab |
R03DX10 |
AstraZeneca AB |
|
Faslodex
|
fulvestrant |
L02BA03 |
AstraZeneca UK Ltd. |
|
Fastum - geel (2,5%)
|
ketoprofeen |
M02AA10 |
Ideal Trade Links UAB |
|
FASTURTEC
|
rasburikaas |
V03AF07 |
Sanofi Winthrop Industrie |
|
Fasturtec
|
– |
– |
– |
|
Fatroximin - intrauteriintablett (300mg)
|
rifaksimiin |
QG51AA06 |
Fatro S.p.A |
|
Fatroximin - intrauteriinvaht (5,4mg 1ml)
|
rifaksimiin |
QG51AA06 |
Fatro S.p.A |
|
Fatroximin - nahasprei, lahus (2mg 1ml)
|
rifaksimiin |
QD06AX11 |
Fatro S.p.A |
|
Fatroximin dry cow - intramammaarsalv (20mg 1ml)
|
rifaksimiin |
QJ51XX01 |
Fatro S.p.A |
|
Febrilek - õhukese polümeerikattega tablett (200mg +30mg)
|
ibuprofeen +pseudoefedriin |
R05XA82 |
PharmaSwiss Ceska republika s.r.o |
|
Febrisan
|
– |
– |
– |
|
Febrisan C
|
– |
– |
– |
|
Febrivac 3-plus - süstesuspensioon (25000mld100 +10000tcid50 +100000000bakterirakku 1ml)
|
Clostridium inaktiveeritud vaktsiin +naaritsate enteriidi viirus-/parvoviirusvaktsiin +Pseudomonas inaktiveeritud vaktsiin |
QI20CL01 |
IDT Biologika GmbH |
|
Febrivac dist - süstesuspensiooni lüofilisaat ja lahusti (1annus 1ml)
|
naaritsate katku viirusvaktsiin |
QI20CD01 |
IDT Biologika GmbH |
|
Febuxostat alembic - õhukese polümeerikattega tablett (120mg)
|
febuksostaat |
M04AA03 |
Alembic Pharmaceuticals Europe Limited |
|
Febuxostat alembic - õhukese polümeerikattega tablett (80mg)
|
febuksostaat |
M04AA03 |
Alembic Pharmaceuticals Europe Limited |
|
Febuxostat krka
|
febuksostaat |
M04AA03 |
KRKA tovarna zdravil d.d. Novo mesto |
|
Febuxostat teva - õhukese polümeerikattega tablett (120mg)
|
febuksostaat |
M04AA03 |
Teva B.V. |
|
Febuxostat teva - õhukese polümeerikattega tablett (80mg)
|
febuksostaat |
M04AA03 |
Teva B.V. |
|
Febuxostat viatris
|
febuksostaat |
M04AA03 |
Viatris Limited |
|
Feiba - inf subst 1000ü 20 ml lahustit
|
Factor VIII inhibitor bypassing activity |
B02BD03 |
Baxter AG |
|
Feiba - inf subst 500ü 20 ml lahustit
|
Factor VIII inhibitor bypassing activity |
B02BD03 |
Baxter AG |
|
Feiba - süstelahuse pulber ja lahusti (1000ühik)
|
faktor VIII inhibiitorist möödamineva aktiivsusega hüübimisfaktorid |
B02BD03 |
Baxalta Innovations GmbH |
|
Feiba - süstelahuse pulber ja lahusti (500ühik)
|
faktor VIII inhibiitorist möödamineva aktiivsusega hüübimisfaktorid |
B02BD03 |
Baxalta Innovations GmbH |
|
Feiba 100 üml - infusioonilahuse pulber ja lahusti (100ühik 1ml)
|
faktor VIII inhibiitorist möödamineva aktiivsusega hüübimisfaktorid |
B02BD03 |
Baxalta Innovations GmbH |
|
Feiba 25 üml - inf lahuse pulber 500ü n1 lahusti 20ml
|
Factor VIII inhibitor bypassing activity |
B02BD03 |
Baxalta Innovations GmbH |
|
Feiba 25 üml - infusioonilahuse pulber ja lahusti (25ühik 1ml)
|
faktor VIII inhibiitorist möödamineva aktiivsusega hüübimisfaktorid |
B02BD03 |
Baxalta Innovations GmbH |
|
Feiba 50 üml - inf lahuse pulber 1000ü n1 lahusti 20ml; pulber 2500tü n1 lahusti 50ml
|
Factor VIII inhibitor bypassing activity |
B02BD03 |
Baxalta Innovations GmbH |
|
Feiba 50 üml - infusioonilahuse pulber ja lahusti (50ühik 1ml)
|
faktor VIII inhibiitorist möödamineva aktiivsusega hüübimisfaktorid |
B02BD03 |
Baxalta Innovations GmbH |
|
Feldene - geel (0,5%)
|
piroksikaam |
M02AA07 |
Pfizer Europe MA EEIG |
|
Feligen crp - süstesuspensiooni lüofilisaat ja lahusti (1annust)
|
kasside panleukopeenia viirus-/parvoviirusvaktsiin +kasside kalitsiviirusvaktsiin +kasside rinotrahheiidi viirusvaktsiin |
QI06AD04 |
Virbac |
|
Feligen crpr - süstesuspensiooni lüofilisaat ja lahusti (1annust)
|
kasside panleukopeenia viirus-/parvoviirusvaktsiin +marutaudi inaktiveeritud viirusvaktsiin +kasside rinotrahheiidi viirusvaktsiin +kasside kalitsiviirusvaktsiin |
QI06AH04 |
Virbac |
|
Felodipin hexal - toimeainet prolongeeritult vabastav tablett (10mg)
|
felodipiin |
C08CA02 |
HEXAL AG |
|
Felodipin hexal - toimeainet prolongeeritult vabastav tablett (5mg)
|
felodipiin |
C08CA02 |
HEXAL AG |
|
Felogel - geel (10mg 1g)
|
diklofenak |
M02AA15 |
Sopharma AD |
|
Felora - geel (10mg 1g)
|
diklofenak |
M02AA15 |
Actavis Group PTC ehf |
|
Feloran
|
– |
– |
– |
|
Femara - õhukese polümeerikattega tablett (2,5mg)
|
letrosool |
L02BG04 |
Novartis Baltics SIA |
|
Femina-35
|
– |
– |
– |
|
Femoden - kaetud tablett (0,075mg +0,03mg)
|
gestodeen +etünüülöstradiool |
G03AA10 |
Bayer AG |
|
Femoston - õhukese polümeerikattega tablett (0 +1mg/10mg +1mg)
|
düdrogesteroon +östradiool |
G03FB08 |
MagnaPharm SK s.r.o. |
|
Femoston - tabl 1mg n14;1mg 10mg n14; (n28); n28x3
|
Dydrogesterone Estradiol |
G03FB08 |
BGP Products B.V. |
|
Femoston conti - õhukese polümeerikattega tablett (5mg +1mg)
|
düdrogesteroon +östradiool |
G03FA14 |
MagnaPharm SK s.r.o. |
|
Femoston conti 0,5 mg2,5 mg - õhukese polümeerikattega tablett (2,5mg +0,5mg)
|
düdrogesteroon +östradiool |
G03FA14 |
Mylan Healthcare GmbH |
|
Femtozette
|
– |
– |
– |
|
Fendrix
|
hepatitis B surface antigen |
J07BC01 |
GlaxoSmithKline Biologicals S.A. |
|
Fenivir - kreem (10mg 1g)
|
pentsikloviir |
D06BB06 |
Richard Bittner AG |
|
Fenivir - kreem 10mg / g 2g
|
Penciclovir |
D06BB06 |
Novartis Finland OY |
|
Fenodex - õhukese polümeerikattega tablett (25mg)
|
deksketoprofeen |
M01AE17 |
Medochemie Limited |
|
Fenofibrate
|
– |
– |
– |
|
Fenolip
|
– |
– |
– |
|
Fentanyl actavis
|
– |
– |
– |
|
Fentanyl basi - süste-/infusioonilahus (50mcg 1ml)
|
fentanüül |
N01AH01 |
Laboratorios Basi Industria Farmaceutica S.A. |
|
Fentanyl kalceks - süstelahus (50mcg 1ml)
|
fentanüül |
N01AH01 |
Kalceks AS |
|
Fentanyl sandoz
|
– |
– |
– |
|
Fentanyl-richter - inj 0,05mg / ml amp 5ml n50
|
Fentanyl |
N01AH01 |
Gedeon Richter Plc. |
|
Fentanyl-richter - süstelahus (0,05mg 1ml)
|
fentanüül |
N01AH01 |
Gedeon Richter Plc. |
|
Fentora
|
– |
– |
– |
|
Feraccru - kõvakapsel (30mg)
|
raud(III)maltool |
B03AB10 |
Norgine B.V. |
|
Ferant - süstelahus (250mcg 5ml)
|
palonosetroon |
A04AA05 |
Medochemie Limited |
|
Ferant - süstelahus (50mcg 1ml)
|
palonosetroon |
A04AA05 |
Medochemie Ltd. |
|
Fercelan - kõvakapsel (202,8mg +0,8mg +100mg)
|
raud(II)fumaraat +foolhape +askorbiinhape |
B03AE82 |
G.L. Pharma GmbH |
|
Fercevit - kõvakapsel (202,8mg +0,8mg +100mg)
|
raud(II)fumaraat +foolhape +askorbiinhape |
B03AE82 |
G.L. Pharma GmbH |
|
Feremazol - õhukese polümeerikattega tablett (2,5mg)
|
letrosool |
L02BG04 |
Remedica Limited |
|
Ferinject - süste-/infusioonidispersioon (50mg 1ml)
|
raudkarboksümaltoos |
B03AC85 |
Vifor France |
|
Ferinject - süste-/infusioonilahus (50mg 1ml)
|
dekstriferroon |
B03AC01 |
Vifor France |
|
Ferion
|
– |
– |
– |
|
Ferretab comp. - toimeainet prolongeeritult vabastav kõvakapsel (152,1mg +0,5mg)
|
raud(II)fumaraat +foolhape |
B03AD02 |
Lex Ano UAB |
|
Ferriprox
|
deferiproon |
V03AC02 |
Chiesi Farmaceutici S.p.A. |
|
Ferrola - gastroresistentne tablett (114mg +0,8mg)
|
raud(II)sulfaat +foolhape |
B03AD03 |
WÖRWAG PHARMA GmbH & Co. KG |
|
Ferrologic
|
– |
– |
– |
|
Ferrologic 20mgml - süstelahus või inf lahuse konts. 20mg / ml n5; 10pakk n5
|
Iron (III) hydroxide sucrose complex |
B03AC02 |
Fresenius Medical Care Nephrologica Deutschland GmbH |
|
Ferrovet - süstelahus (100mg 1ml)
|
rauddekstraan |
QB03AC90 |
Vetoquinol Biowet Sp.z o.o |
|
Ferrum lek
|
Iron (III) hydroxide polymaltose complex |
B03AB80 |
Lek Pharmaceuticals d.d. |
|
Ferrum lek - inj lahus 50mg / ml 2ml n5; n50
|
Iron (III)-hydroxide dextran complex |
B03AC06 |
Lek Pharmaceuticals d.d. |
|
Ferrum lek - närimistablett (100mg)
|
raud(III)hüdroksiid-polümaltooskompleks |
B03AB80 |
Sandoz Pharmaceuticals d.d. |
|
Ferrum lek - siirup (10mg 1ml)
|
raud(III)hüdroksiid-polümaltooskompleks |
B03AB80 |
Sandoz Pharmaceuticals d.d. |
|
Ferrum lek - siirup 10mg / ml 100ml n1
|
Iron (III) hydroxide polymaltose complex |
B03AB80 |
Lek Pharmaceuticals d.d. |
|
Ferrum lek - süstelahus (50mg 1ml)
|
raud(III)hüdroksiidi ja dekstraani kompleks |
B03AC84 |
Sandoz Pharmaceuticals d.d. |
|
FERTAVID
|
follitropin beta |
G03GA06 |
Merck Sharp & Dohme Ltd.
|
|
FERVEX
|
Paracetamol Pheniramine Ascorbic acid |
N02BE85 |
Bristol-Myers Squibb Gyogyszerkereskedelmi Kft. |
|
Fervex - graanulid lahuse valmistamiseks 500mg 25mg 200mg n6; n8
|
Paracetamol Pheniramine Ascorbic acid |
N02BE85 |
Bristol-Myers Squibb Gyogyszerkereskedelmi Kft. |
|
Fervex - suukaudse lahuse graanulid (100mg +10mg +280mg)
|
paratsetamool +feniramiin +askorbiinhape |
N02BE85 |
Bristol-Myers Squibb Gyogyszerkereskedelmi Kft. |
|
Fervex - suukaudse lahuse graanulid (280mg +10mg +100mg)
|
paratsetamool +feniramiin +askorbiinhape |
N02BE85 |
Ideal Trade Links UAB |
|
Fervex - suukaudse lahuse graanulid (500mg +25mg +200mg)
|
paratsetamool +feniramiin +askorbiinhape |
N02BE85 |
UPSA S.A.S. |
|
Fervex (suhkruvaba) - suukaudse lahuse graanulid (200mg +25mg +500mg)
|
paratsetamool +feniramiin +askorbiinhape |
N02BE85 |
Bristol-Myers Squibb Gyogyszerkereskedelmi Kft. |
|
Fervex (suhkruvaba) - suukaudse lahuse graanulid (500mg +25mg +200mg)
|
paratsetamool +feniramiin +askorbiinhape |
N02BE85 |
UPSA S.A.S. |
|
Fetcroja - infusioonilahuse kontsentraadi pulber (1g)
|
tsefiderokool |
J01DI04 |
Shionogi B.V. |
|
Fevarin - õhukese polümeerikattega tablett (100mg)
|
fluvoksamiin |
N06AB08 |
Viatris SIA |
|
Fevarin - õhukese polümeerikattega tablett (50mg)
|
fluvoksamiin |
N06AB08 |
Viatris SIA |
|
Fiasp
|
aspart-insuliin |
A10AB05 |
Novo Nordisk A/S |
|
Fibryga
|
humaanfibrinogeen |
B02BB01 |
Octapharma (IP) SPRL |
|
Fildlata
|
– |
– |
– |
|
Filgrastim Hexal
|
filgrastim |
L03AA02 |
Hexal AG |
|
Filspari
|
sparsentaan |
C09XX01 |
Vifor France |
|
Filsuvez - geel (100mg 1g)
|
kasetohuekstrakt |
D03AX13 |
Chiesi Farmaceutici S.p.A. |
|
Finacea
|
– |
– |
– |
|
Finacea - geel (150mg 1g)
|
aselaiinhape |
D10AX03 |
LEO Pharma A/S |
|
Finacea - geel 150mg / g 5g n1; 10g n1; 15g n1; 30g n1; 50g n1
|
Azelaic acid |
D10AX03 |
Bayer Pharma AG |
|
Finadyne vet. - kriipsulahus (50mg 1ml)
|
fluniksiin |
QM01AG90 |
Intervet International B.V. |
|
Finalgon - salv (25mg +4mg 1g)
|
nikoboksiil +nonivamiid |
M02AX80 |
Sanofi-Aventis Estonia OÜ |
|
Finasterid actavis
|
– |
– |
– |
|
Finasteride accord
|
Finasteride |
G04CB01 |
Accord Healthcare Limited |
|
Finasteride accord - õhukese polümeerikattega tablett (1mg)
|
finasteriid |
D11AX10 |
Accord Healthcare Limited |
|
Finasteride accord - õhukese polümeerikattega tablett (5mg)
|
finasteriid |
G04CB01 |
Accord Healthcare Limited |
|
Finasteride aurobindo - õhukese polümeerikattega tablett (5mg)
|
finasteriid |
G04CB01 |
Aurobindo Pharma Limited |
|
Finasteride portfarma 5mg - tabl 5mg n30; n15; n100; n28; n98
|
Finasteride |
G04CB01 |
Portfarma ehf |
|
Finasteride teva - õhukese polümeerikattega tablett (5mg)
|
finasteriid |
G04CB01 |
Teva Pharma B.V. |
|
Finasteride teva - tabl 5mg n14 (r); n15 (r); n20 (r); n28 (r); n30 (r); n50 (h); n56 (r); n60 (r); n84 (r); n90 (r); n98 (r); n100 (h); n105 (h) n120 (h)
|
Finasteride |
G04CB01 |
Teva Pharma B.V. |
|
Fingolimod accord - kõvakapsel (0,5mg)
|
fingolimood |
L04AE01 |
Accord Healthcare S.L.U. |
|
Fingolimod msn - kõvakapsel (0,5mg)
|
fingolimood |
L04AE01 |
MSN Labs Europe Limited |
|
Fingolimod mylan - kõvakapsel (0,5mg)
|
fingolimood |
L04AE01 |
Mylan Pharmaceuticals Limited |
|
Fingolimod norameda - kõvakapsel (0,5mg)
|
fingolimood |
L04AE01 |
Norameda UAB |
|
Fingolimod olpha - kõvakapsel (0,5mg)
|
fingolimood |
L04AE01 |
Olpha AS |
|
Fingolimod remedica - kõvakapsel (0,5mg)
|
fingolimood |
L04AE01 |
Remedica Limited |
|
Fingolimod richter - kõvakapsel (0,5mg)
|
fingolimood |
L04AE01 |
Gedeon Richter Plc. |
|
Fingolimod zentiva - kõvakapsel (0,5mg)
|
fingolimood |
L04AE01 |
Zentiva k.s. |
|
Finilac vet - suukaudne lahus (50mcg 1ml)
|
kabergoliin |
QG02CB03 |
Le Vet. Beheer B.V. |
|
Finlee - dispergeeruv tablett (10mg)
|
dabrafeniib |
L01EC02 |
Novartis Europharm Limited |
|
Finlepsin - tablett (200mg)
|
karbamasepiin |
N03AF01 |
Teva Pharma B.V. |
|
Finlepsin - toimeainet modifitseeritult vabastav tablett (200mg)
|
karbamasepiin |
N03AF01 |
Teva Pharma B.V. |
|
Finlepsin - toimeainet modifitseeritult vabastav tablett (400mg)
|
karbamasepiin |
N03AF01 |
Teva Pharma B.V. |
|
Finogi
|
flukloksatsilliin |
J01CF05 |
Medochemie Limited |
|
Finoten - kõrvatilgad, lahus (40mg +10mg 1g)
|
fenasoon +lidokaiin |
S02DA81 |
Sopharma AD |
|
Finpros 5 mg - õhukese polümeerikattega tablett (5mg)
|
finasteriid |
G04CB01 |
KRKA d.d., Novo mesto |
|
Fintepla - suukaudne lahus (2,2mg 1ml)
|
fenfluramiin |
N03AX26 |
UCB Pharma |
|
Fiprex - täpilahus (75mg 1ml)
|
fiproniil |
QP53AX15 |
Multi-Trade Company Vet-Agro Sp. z.o.o |
|
Fipron - täpilahus (134mg 1.34ml)
|
fiproniil |
QP53AX15 |
Bioveta a.s. |
|
Fipron - täpilahus (268mg 2.68ml)
|
fiproniil |
QP53AX15 |
Bioveta a.s. |
|
Fipron - täpilahus (402mg 4.02ml)
|
fiproniil |
QP53AX15 |
Bioveta a.s. |
|
Fipron - täpilahus (50mg 0.5ml)
|
fiproniil |
QP53AX15 |
Bioveta a.s. |
|
Fipron - täpilahus (67mg 0.67ml)
|
fiproniil |
QP53AX15 |
Bioveta a.s. |
|
Firazyr
|
ikatibant |
C01EB19 |
Takeda Pharmaceuticals International AG Ireland Branch |
|
Firdapse
|
amifampridiin |
N07XX05 |
Serb |
|
Firmagon
|
degarelix |
L02BX02 |
Ferring Pharmaceuticals A/S |
|
Fivotta
|
dapagliflosiin |
A10BK01 |
Gedeon Richter Plc. |
|
Fixopost - silmatilgad, lahus üheannuselises konteineris (5mg +50mcg 1ml)
|
timolool +latanoprost |
S01ED84 |
Laboratoires Théa |
|
Flavamed 30 mg - tablett (30mg)
|
ambroksool |
R05CB06 |
Berlin-Chemie AG (Menarini Group) |
|
Flavamed 30 mg/5 ml
|
– |
– |
– |
|
Flavamed 60mg - kihisev tablett (60mg)
|
ambroksool |
R05CB06 |
Berlin-Chemie AG (Menarini Group) |
|
Flavamed forte - suukaudne lahus (6mg 1ml)
|
ambroksool |
R05CB06 |
Berlin-Chemie AG (Menarini Group) |
|
Flavamed forte - suukaudne lahus 6mg / ml 100ml n1
|
Ambroxol |
R05CB06 |
Berlin-Chemie AG (Menarini Group) |
|
Flavamed vaarikas - suukaudne lahus (3mg 1ml)
|
ambroksool |
R05CB06 |
Berlin-Chemie AG (Menarini Group) |
|
Flazonexar - ninasprei, suspensioon (50mcg +137mcg 1mõõtannus)
|
flutikasoon +aselastiin |
R01AD81 |
Sandoz Pharmaceuticals d.d. |
|
Flea and tick collar - ravimkaelarihm (150mg 1g)
|
dimpülaat |
QP53AF03 |
Beaphar B.V. |
|
Flebaven - õhukese polümeerikattega tablett (500mg)
|
diosmiin |
C05CA03 |
Krka, d.d. Novo mesto |
|
Flebaven - tablett (1000mg)
|
diosmiin |
C05CA03 |
Krka, d.d. Novo mesto |
|
Flebogamma DIF
|
immunoglobuliin, intravaskulaarseks kasutamiseks |
J06BA02 |
Instituto Grifols S.A. |
|
Fleree - intrauteriinne ravivahend (13,5mg)
|
levonorgestreel |
G02BA03 |
Bayer AG |
|
Flevox - täpilahus (134mg 1.34ml)
|
fiproniil |
QP53AX15 |
Vetoquinol SA |
|
Flevox - täpilahus (268mg 2.68ml)
|
fiproniil |
QP53AX15 |
Vetoquinol SA |
|
Flevox - täpilahus (402mg 4.02ml)
|
fiproniil |
QP53AX15 |
Vetoquinol SA |
|
Flevox - täpilahus (50mg 0.5ml)
|
fiproniil |
QP53AX15 |
Vetoquinol SA |
|
Flevox - täpilahus (67mg 0.67ml)
|
fiproniil |
QP53AX15 |
Vetoquinol SA |
|
Flexbumin 200 gl - infusioonilahus (200mg 1ml)
|
albumiin |
B05AA01 |
Baxalta Innovations GmbH |
|
Flexigran
|
– |
– |
– |
|
Flexilev - dispergeeruvad tabletid annustis kasutamiseks (5mg +1,25mg)
|
levodopa +karbidopa |
N04BA81 |
Sensidose AB |
|
Flimabend - suspensioon joogivees manustamiseks (100mg 1g)
|
flubendasool |
QP52AC12 |
KRKA d.d., Novo mesto |
|
Flixabi - infusioonilahuse kontsentraadi pulber (100mg)
|
infliksimab |
L04AB02 |
Samsung Bioepis NL B.V. |
|
Flixonase - ninasprei, suspensioon (50mcg 1mõõtannus)
|
flutikasoon |
R01AD08 |
Haleon Hungary Kft. |
|
Flixonase - ninasprei, suspensioon (50mcg 1pihustus)
|
flutikasoon |
R01AD08 |
GlaxoSmithKline Dungarvan Limited |
|
Flixonase aqueous nasal spray 50 mcg - ninasprei, susp 50mcg / 1annust 60annust n1
|
Fluticasone |
R01AD08 |
Glaxo Wellcome UK Limited |
|
Flixonase aqueous nasal spray 50 mcg - ninasprei, suspensioon (50mcg 1annus)
|
flutikasoon |
R01AD08 |
GlaxoSmithKline Trading Services Limited |
|
Flixonase aqueous nasal spray 50 mcg - ninasprei, suspensioon (50mcg 1annust)
|
flutikasoon |
R01AD08 |
Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations |
|
Flixotide diskus 100 mcg - inhal pulb 100mcg / annuses 60annust
|
Fluticasone |
R03BA05 |
Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations |
|
Flixotide diskus 100 mcg - inhalatsioonipulber (100mcg 1annus)
|
flutikasoon |
R03BA05 |
GlaxoSmithKline Trading Services Limited |
|
Flixotide diskus 100 mcg - inhalatsioonipulber (100mcg 1annust)
|
flutikasoon |
R03BA05 |
Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations |
|
Flixotide diskus 250 mcg - inhal pulber 250mcg / annuses 60 annust
|
Fluticasone |
R03BA05 |
Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations |
|
Flixotide diskus 250 mcg - inhalatsioonipulber (250mcg 1annus)
|
flutikasoon |
R03BA05 |
GlaxoSmithKline Trading Services Limited |
|
Flixotide diskus 250 mcg - inhalatsioonipulber (250mcg 1annust)
|
flutikasoon |
R03BA05 |
Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations |
|
Flixotide diskus 50 mcg - inhal pulber 50mcg / annuses 60 annust
|
Fluticasone |
R03BA05 |
Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations |
|
Flixotide diskus 50 mcg - inhalatsioonipulber (50mcg 1annus)
|
flutikasoon |
R03BA05 |
GlaxoSmithKline Trading Services Limited |
|
Flixotide diskus 50 mcg - inhalatsioonipulber (50mcg 1annust)
|
flutikasoon |
R03BA05 |
Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations |
|
Flixotide inhaler - inhal aeros, susp 50mcg / annuses 120annust
|
Fluticasone |
R03BA05 |
Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations |
|
Flixotide inhaler - inhalatsiooniaerosool, suspensioon (50mcg 1annus)
|
flutikasoon |
R03BA05 |
GlaxoSmithKline Trading Services Limited |
|
Flixotide inhaler - inhalatsiooniaerosool, suspensioon (50mcg 1annust)
|
flutikasoon |
R03BA05 |
Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations |
|
Flolan - infusioonilahuse pulber ja lahusti (500mcg)
|
epoprostenool |
B01AC09 |
Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations |
|
Flomax
|
– |
– |
– |
|
Flordofen - süstelahus (300mg 1ml)
|
florfenikool |
QJ01BA90 |
Dopharma Research B.V. |
|
Florkem - süstelahus (300mg 1ml)
|
florfenikool |
QJ01BA90 |
Ceva Santé Animale |
|
Floron 100mgml - suukaudne lahus (100mg 1ml)
|
florfenikool |
QJ01BA90 |
KRKA d.d., Novo mesto |
|
Floron 300mgml - süstelahus (300mg 1ml)
|
florfenikool |
QJ01BA90 |
KRKA d.d., Novo mesto |
|
Flosin 0,4mg - toimeainet modifitseeritult vabastav kõvakapsel (0,4mg)
|
tamsulosiin |
G04CA02 |
Menarini International Operations Luxembourg S.A. |
|
Floxelan - õhukese polümeerikattega tablett (400mg)
|
moksifloksatsiin |
J01MA14 |
Medochemie Limited |
|
Floxin
|
– |
– |
– |
|
Fluad - süstesuspensioon süstlis (1annus 0.5ml)
|
gripiviirus, inaktiveeritud, tükeldatud viirus või pinnaantigeen |
J07BB02 |
Seqirus Netherlands B.V. |
|
Fluanxol - õhukese polümeerikattega tablett (1mg)
|
flupentiksool |
N05AF01 |
H. LUNDBECK A/S |
|
Fluanxol depot - inj 20mg / ml amp 1ml n1
|
Flupentixol |
N05AF01 |
H. LUNDBECK A/S |
|
Fluanxol depot - süstelahus (20mg 1ml)
|
flupentiksool |
N05AF01 |
H. LUNDBECK A/S |
|
Fluarix - inj susp / 0,5ml n1; n10; n20
|
Influenza, inactivated, split virus or surface antigen |
J07BB02 |
GlaxoSmithKline Biologicals s.a. |
|
Fluarix - süstesuspensioon (1annust 0.5ml)
|
gripiviirus, inaktiveeritud, tükeldatud viirus või pinnaantigeen |
J07BB02 |
GlaxoSmithKline Biologicals s.a. |
|
Fluarix tetra - süstesuspensioon süstlis (1annus 0.5ml)
|
gripiviirus, inaktiveeritud, tükeldatud viirus või pinnaantigeen |
J07BB02 |
GlaxoSmithKline Eesti OÜ |
|
Flubenol kh - suukaudne pasta (44mg 1ml)
|
flubendasool |
QP52AC12 |
Eli Lilly Regional Operations GmbH |
|
Flucelvax - süstesuspensioon süstlis (1annus 0.5ml)
|
gripiviirus, inaktiveeritud, tükeldatud viirus või pinnaantigeen |
J07BB02 |
Seqirus Netherlands B.V. |
|
Fluconazol nycomed 150mg - kõvakapsel 150mg n1; n2
|
Fluconazole |
J02AC01 |
Takeda Pharma AS |
|
Fluconazol takeda 150mg - kõvakapsel (150mg)
|
flukonasool |
J02AC01 |
Takeda Pharma AS |
|
Fluconazole actavis - kõvakapsel (100mg)
|
flukonasool |
J02AC01 |
Actavis Group PTC ehf |
|
Fluconazole actavis - kõvakapsel (150mg)
|
flukonasool |
J02AC01 |
Teva B.V. |
|
Fluconazole actavis - kõvakapsel (200mg)
|
flukonasool |
J02AC01 |
Actavis Group PTC ehf |
|
Fluconazole actavis - kõvakapsel (50mg)
|
flukonasool |
J02AC01 |
Actavis Group PTC ehf |
|
Fluconazole claris - infusioonilahus (2mg 1ml)
|
flukonasool |
J02AC01 |
Claris Lifesciences (UK) Limited |
|
Fluconazole elvim - infusioonilahus (2mg 1ml)
|
flukonasool |
J02AC01 |
SIA Elvim |
|
Fluconazole elvim - kõvakapsel (150mg)
|
flukonasool |
J02AC01 |
SIA ELVIM |
|
Fluconazole elvim - kõvakapsel (50mg)
|
flukonasool |
J02AC01 |
SIA ELVIM |
|
Fluconazole medochemie - kõvakapsel (150mg)
|
flukonasool |
J02AC01 |
Medochemie Ltd. |
|
Fluconazole medochemie - kõvakapsel (50mg)
|
flukonasool |
J02AC01 |
Medochemie Ltd. |
|
Fluconazole portfarma - caps 150mg n1; n2; n4
|
Fluconazole |
J02AC01 |
Portfarma ehf |
|
Fluconazole portfarma - caps 50mg n7; n10; n14; n20; n28; n30; n50; n100
|
Fluconazole |
J02AC01 |
Portfarma ehf |
|
Fluconazole sandoz 100mg
|
– |
– |
– |
|
Fluconazole sandoz 150mg - kõvakapsel (150mg)
|
flukonasool |
J02AC01 |
Sandoz Pharmaceuticals d.d. |
|
Fluconazole sandoz 50mg - kõvakapsel (50mg)
|
flukonasool |
J02AC01 |
Sandoz Pharmaceuticals d.d. |
|
Fluconazole teva - kõvakapsel (150mg)
|
flukonasool |
J02AC01 |
Teva B.V. |
|
Fluconazole vitabalans - tablett (150mg)
|
flukonasool |
J02AC01 |
Vitabalans Oy |
|
Fludara
|
– |
– |
– |
|
Fludarabine accord 25 mgml - süste-/infusioonilahuse kontsentraat (25mg 1ml)
|
fludarabiin |
L01BB05 |
Accord Healthcare Limited |
|
Fludarabine actavis - süste-/infusioonilahuse kontsentraat (25mg 1ml)
|
fludarabiin |
L01BB05 |
Actavis Group PTC ehf |
|
Fludarabine ebewe 25mgml - süste-/infusioonilahuse kontsentraat (25mg 1ml)
|
fludarabiin |
L01BB05 |
Sandoz Pharmaceuticals d.d. |
|
Fludarabine kabi 50 mg - inj / inf lahuse pulber 50mg n1
|
Fludarabine |
L01BB05 |
Fresenius Kabi Oncology Plc. |
|
Fludarabine-Teva 25 mg/ml
|
– |
– |
– |
|
Fludeomap - süstelahus (250mbq 1ml)
|
fludeoksüglükoos (18F) |
V09IX04 |
MAP Medical Technologies Oy |
|
Fluditec - siirup (20mg 1ml)
|
karbotsüsteiin |
R05CB03 |
LABORATOIRE INNOTECH INTERNATIONAL |
|
Fluditec - siirup (50mg 1ml)
|
karbotsüsteiin |
R05CB03 |
LABORATOIRE INNOTECH INTERNATIONAL |
|
Fluditec - siirup 20 mg / ml 125ml
|
Carbocisteine |
R05CB03 |
LABORATOIRE INNOTECH INTERNATIONAL |
|
Fluditec - siirup 50 mg / ml 125ml
|
Carbocisteine |
R05CB03 |
LABORATOIRE INNOTECH INTERNATIONAL |
|
Fluenz
|
gripiviirus, elus, nõrgestatud |
J07BB03 |
AstraZeneca AB |
|
FluLaval
|
– |
– |
– |
|
Flumazenil pharmaselect 0,1mgml - süst / inf konts 0,1mg / 1ml 5ml n5; 5ml n10; 10ml n5; 10ml n10
|
Flumazenil |
V03AB25 |
Pharmaselect International Beteiligungs GmbH |
|
FluMist
|
– |
– |
– |
|
Flunoc - kõvakapsel (150mg)
|
flukonasool |
J02AC01 |
Sandoz Pharmaceuticals d.d. |
|
Fluorescite - süstelahus (100mg 1ml)
|
fluorestseiin |
S01JA01 |
s.a. Alcon-Couvreur N.V. |
|
Fluorocholine (18f) synektik - süstelahus (1gbq 1ml)
|
fluorometüülkoliin (18F) |
V09IX07 |
SYNEKTIK S.A. |
|
Fluorouracil Accord
|
– |
– |
– |
|
Fluorouracil accord 50 mgml süste-või infusioonilahus - süste-/infusioonilahus (50mg 1ml)
|
fluorouratsiil |
L01BC02 |
Accord Healthcare Limited |
|
Fluoxetine vitabalans - õhukese polümeerikattega tablett (20mg)
|
fluoksetiin |
N06AB03 |
VITABALANS OY |
|
Flupirtine Zentiva 100 mg
|
– |
– |
– |
|
Flurbiprofen stada - loseng (8,75mg)
|
flurbiprofeen |
R02AX01 |
Stada Arzneimittel AG |
|
Flurbiprofen stadacare - loseng (8,75mg)
|
flurbiprofeen |
R02AX01 |
Stada Arzneimittel AG |
|
Flusamer - annustatud inhalatsioonipulber (50mcg +250mcg)
|
salmeterool +flutikasoon |
R03AK06 |
ELPEN Pharmaceutical Co.Inc (SA) |
|
Flusamer - annustatud inhalatsioonipulber (50mcg +500mcg)
|
salmeterool +flutikasoon |
R03AK06 |
ELPEN Pharmaceutical Co.Inc (SA) |
|
Flutensif - toimeainet modifitseeritult vabastav tablett (10mg +1,5mg)
|
amlodipiin +indapamiid |
C08GA80 |
Les Laboratoires Servier |
|
Flutensif - toimeainet modifitseeritult vabastav tablett (5mg +1,5mg)
|
amlodipiin +indapamiid |
C08GA80 |
Les Laboratoires Servier |
|
Fluticasone propionate gsk - ninasprei, suspensioon (50mcg 1annust)
|
flutikasoon |
R01AD08 |
Glaxo Wellcome UK Limited |
|
Fluticasone teva - ninasprei, suspensioon (27,5mcg 1mõõtannus)
|
flutikasoonfuroaat |
R01AD12 |
Teva B.V. |
|
Fluvastatin accord - toimeainet prolongeeritult vabastav tablett (80mg)
|
fluvastatiin |
C10AA04 |
Accord Healthcare Limited |
|
Fluvastatin actavis - toimeainet prolongeeritult vabastav tablett (80mg)
|
fluvastatiin |
C10AA04 |
Teva B.V. |
|
Fluvastatin actavis 20mg
|
– |
– |
– |
|
Fluvastatin actavis 40mg
|
– |
– |
– |
|
Flux - kõvakapsel (20mg)
|
fluoksetiin |
N06AB03 |
Sandoz Pharmaceuticals d.d. |
|
Fluxemed 20mg
|
– |
– |
– |
|
Flynise - suus dispergeeruv tabl 2,5mg n7 (k); n10 (k); n20 (r); n30 (r); n50 (r); n60 (r); n90 (r); n5 (k); n6 (k); n12 (r); n15 (r); n100 (r)
|
Desloratadine |
R06AX27 |
Actavis Group PTC ehf |
|
Flynise - suus dispergeeruv tabl 5mg n7 (k); n10 (k); n20 (r); n30 (r); n50 (r); n60 (r); n90 (r); n5 (k); n6 (k); n12 (r); n15 (r); n100 (r); n18 (r)
|
Desloratadine |
R06AX27 |
Actavis Group PTC ehf |
|
Focetria
|
Influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: A/California/7/2009 (H1N1)-derived strain used NYMC X-181 7.5 microgragms per 0.5 ml dose |
J07BB02 |
Novartis Vaccines and Diagnostics S.r.l. |
|
Foclivia
|
gripiviirus, inaktiveeritud, tükeldatud viirus või pinnaantigeen |
J07BB02 |
Seqirus S.r.l. |
|
Fokusin - toimeainet modifitseeritult vabastav kõvakapsel (0,4mg)
|
tamsulosiin |
G04CA02 |
Takeda GmbH |
|
Folic acid auxilia
|
foolhape |
B03BB01 |
Auxilia Pharma OÜ |
|
Folic acid vitabalans - tablett (5mg)
|
foolhape |
B03BB01 |
Vitabalans Oy |
|
Folifer - gastroresistentne tabl 114mg 0,8mg n20; n50; n100
|
Ferrous sulphate Folic acid |
B03AD03 |
WÖRWAG PHARMA GmbH & Co. KG |
|
Folligon 1000 - süstelahuse pulber ja lahusti (1000rü)
|
seerumgonadotropiin |
QG03GA03 |
Intervet International B.V. |
|
Follistim
|
– |
– |
– |
|
Fomeda easyhaler - inhalatsioonipulber (12mcg 1annus)
|
formoterool |
R03AC13 |
Orion Corporation |
|
Fomeda easyhaler - inhalatsioonipulber (12mcg 1annust)
|
formoterool |
R03AC13 |
Orion Corporation |
|
Fomeda easyhaler - inhaleeritav pulber 12mcg / annuses 120annust n1; 120annust n2
|
Formoterol |
R03AC13 |
Orion Corporation |
|
Fongitar
|
– |
– |
– |
|
Foradil aerolizer - inhalatsioonipulber kõvakapslis (12mcg)
|
formoterool |
R03AC13 |
SIA Novartis Baltics |
|
Forane - inhalatsiooniaur, vedelik
|
isofluraan |
N01AB06 |
AbbVie Limited |
|
Forcyl - süstelahus (160mg 1ml)
|
marbofloksatsiin |
QJ01MA93 |
Vetoquinol SA |
|
Forcyl swine - süstelahus (160mg 1ml)
|
marbofloksatsiin |
QJ01MA93 |
Vetoquinol SA |
|
Foresto - ravimkaelarihm (0,56g +1,25g 12.5g)
|
flumetriin +imidaklopriid |
QP53AC83 |
Bayer Animal Health GmbH |
|
Foresto - ravimkaelarihm (2,03g +4,5g 45g)
|
flumetriin +imidaklopriid |
QP53AC83 |
Bayer Animal Health GmbH |
|
Forlax 10g - suukaudse lahuse pulber (10g)
|
makrogool |
A06AD15 |
Ipsen Pharma |
|
Forlax 10g - suukaudse lahuse pulber kotikeses (10g)
|
makrogool |
A06AD15 |
Mayoly Pharma France |
|
Forlax 4g - suukaudse lahuse pulber (4g)
|
makrogool |
A06AD15 |
Ipsen Pharma |
|
Forlax 4g - suukaudse lahuse pulber kotikeses (4g)
|
makrogool |
A06AD15 |
Mayoly Pharma France |
|
Forsium - pehmekapsel (400mg)
|
ibuprofeen |
M01AE01 |
AS Grindeks |
|
Forsteo
|
teriparatiid |
H05AA02 |
Eli Lilly Nederland B.V. |
|
Fortacin - nahasprei, lahus (150mg +50mg 1ml)
|
lidokaiin +prilokaiin |
N01BB83 |
Recordati Ireland Limited |
|
Forthyron flavour - tablett (200mcg)
|
naatriumlevotüroksiin |
QH03AA01 |
Eurovet Animal Health B.V. |
|
Forthyron flavour - tablett (400mcg)
|
naatriumlevotüroksiin |
QH03AA01 |
Eurovet Animal Health B.V. |
|
Forthyron flavour - tablett (600mcg)
|
naatriumlevotüroksiin |
QH03AA01 |
Eurovet Animal Health B.V. |
|
Forthyron flavour - tablett (800mcg)
|
naatriumlevotüroksiin |
QH03AA01 |
Eurovet Animal Health B.V. |
|
Fortrans - pulber 5,7g 0,75g 1,46g 1,68g 64g n4
|
Sodium sulphate, anhydrous Potassium chloride Sodium chloride Macrogol Sodium hydrogen carbonate |
A06AD81 |
Ipsen Pharma |
|
Fortrans - suukaudse lahuse pulber (5,7g +0,75g +1,46g +64g +1,68g)
|
naatriumsulfaat, veevaba +kaaliumkloriid +naatriumkloriid +makrogool +naatriumvesinikkarbonaat |
A06AD81 |
Ipsen Pharma |
|
Fortrans - suukaudse lahuse pulber kotikeses (5,7g +0,75g +1,46g +64g +1,68g)
|
naatriumsulfaat, veevaba +kaaliumkloriid +naatriumkloriid +makrogool +naatriumvesinikkarbonaat |
A06AD81 |
Mayoly Pharma France |
|
Fortulin novolizer - inhalatsioonipulber (12mcg 1annuses)
|
formoterool |
R03AC13 |
SIA Meda Pharma |
|
Fortulin novolizer - inhalatsioonipulber (6mcg 1annuses)
|
formoterool |
R03AC13 |
SIA Meda Pharma |
|
Fortum - süste-/infusioonilahuse pulber (1000mg)
|
tseftasidiim |
J01DD02 |
Glaxo Group Ltd. |
|
Fortzaar
|
– |
– |
– |
|
Forvel - süste-/infusioonilahus (0,4mg 1ml)
|
naloksoon |
V03AB15 |
Medochemie Ltd |
|
Forxiga
|
dapagliflozin propanediol monohydrate |
A10BX09 |
AstraZeneca AB |
|
Fosamax
|
– |
– |
– |
|
FOSAMAX 70 mg
|
– |
– |
– |
|
Fosavance
|
alendroonhape +kolekaltsiferool |
M05BB03 |
Organon N.V. |
|
Foscan
|
temoporfin |
L01XD05 |
Biolitec Pharma Limited |
|
Foscarnet sodium tillomed - infusioonilahus (24mg 1ml)
|
naatriumfoskarnet |
J05AD01 |
Tillomed Pharma GmbH |
|
Fosclera
|
dimetüülfumaraat |
L04AX07 |
Norameda UAB |
|
Fosfomycin ladee pharma - suukaudse lahuse graanulid (3g)
|
fosfomütsiin |
J01XX01 |
Exeltis Baltics, UAB |
|
Fosfomycin ladee pharma - suukaudse lahuse gran 3g n1; n2
|
Fosfomycin |
J01XX01 |
Exeltis Baltics, UAB |
|
Fosfomycin zentiva - suukaudse lahuse graanulid kotikeses (2g)
|
fosfomütsiin |
J01XX01 |
Zentiva k.s. |
|
Fosfomycin zentiva - suukaudse lahuse graanulid kotikeses (3g)
|
fosfomütsiin |
J01XX01 |
Zentiva k.s. |
|
Fosinopril actavis - tablett (10mg)
|
fosinopriil |
C09AA09 |
Teva B.V. |
|
Fosinopril actavis - tablett (20mg)
|
fosinopriil |
C09AA09 |
Teva B.V. |
|
Fosinopril actavis - tablett (5mg)
|
fosinopriil |
C09AA09 |
Actavis Nordic A/S |
|
Fosinopril hct actavis - tablett (20mg +12,5mg)
|
fosinopriil +hüdroklorotiasiid |
C09BA87 |
Teva B.V. |
|
Fosrenol - närimistablett (1000mg)
|
lantaan |
V03AE03 |
Takeda Pharmaceuticals International AG Ireland Branch |
|
Fosrenol - närimistablett (250mg)
|
lantaan |
V03AE03 |
Takeda Pharmaceuticals International AG Ireland Branch |
|
Fosrenol - närimistablett (500mg)
|
lantaan |
V03AE03 |
Takeda Pharmaceuticals International AG Ireland Branch |
|
Fosrenol - närimistablett (750mg)
|
lantaan |
V03AE03 |
Takeda Pharmaceuticals International AG Ireland Branch |
|
Fosrenol - suukaudne pulber (1000mg)
|
lantaan |
V03AE03 |
Takeda Pharmaceuticals International AG Ireland Branch |
|
Fosrenol - suukaudne pulber (750mg)
|
lantaan |
V03AE03 |
Takeda Pharmaceuticals International AG Ireland Branch |
|
Foster
|
formoterool +beklometasoon |
R03AK08 |
CHIESI Pharmaceuticals GmbH |
|
Foster - inhal aeros, lahus 6mcg 100mcg / 1annuses 120annust n1; 180annust n1; 120annust n2
|
Formoterol Beclometasone |
R03AK08 |
Chiesi Pharmaceuticals GmbH |
|
Foster - inhalatsiooniaerosool, lahus (6mcg +100mcg 1annust)
|
formoterool +beklometasoon |
R03AK08 |
Chiesi Pharmaceuticals GmbH |
|
Foster - inhalatsiooniaerosool, lahus (6mcg +200mcg 1annust)
|
formoterool +beklometasoon |
R03AK08 |
Chiesi Pharmaceuticals GmbH |
|
Foster nexthaler
|
formoterool +beklometasoon |
R03AK08 |
CHIESI Pharmaceuticals GmbH |
|
Foster nexthaler - inhalatsioonipulber (6mcg +100mcg 1annust)
|
formoterool +beklometasoon |
R03AK08 |
Chiesi Pharmaceuticals GmbH |
|
Foster nexthaler - inhalatsioonipulber (6mcg +200mcg 1annust)
|
formoterool +beklometasoon |
R03AK08 |
Chiesi Pharmaceuticals GmbH |
|
Fotil
|
– |
– |
– |
|
Fotil forte
|
– |
– |
– |
|
Fotivda
|
tivosaniib |
L01EK03 |
Recordati Netherlands B.V. |
|
Foziflum - suukaudse lahuse pulber (3g)
|
fosfomütsiin |
J01XX01 |
Sandoz Pharmaceuticals d.d. |
|
Fragmin - süstelahus süstlis (10000rü anti xa 0.4ml)
|
naatriumdaltepariin |
B01AB04 |
Pfizer Europe MA EEIG |
|
Fragmin - süstelahus süstlis (2500rü anti xa 0.2ml)
|
naatriumdaltepariin |
B01AB04 |
Pfizer Europe MA EEIG |
|
Fragmin - süstelahus süstlis (5000rü anti xa 0.2ml)
|
naatriumdaltepariin |
B01AB04 |
Pfizer Europe MA EEIG |
|
Fragmin - süstelahus süstlis (7500rü anti xa 0.3ml)
|
naatriumdaltepariin |
B01AB04 |
Pfizer Europe MA EEIG |
|
Framsyl - kõvakapsel (16mg +10mg)
|
kandesartaan +amlodipiin |
C09DB07 |
Sandoz Pharmaceuticals d.d. |
|
Framsyl - kõvakapsel (16mg +5mg)
|
kandesartaan +amlodipiin |
C09DB07 |
Sandoz Pharmaceuticals d.d. |
|
Framsyl - kõvakapsel (8mg +10mg)
|
kandesartaan +amlodipiin |
C09DB07 |
Sandoz Pharmaceuticals d.d. |
|
Framsyl - kõvakapsel (8mg +5mg)
|
kandesartaan +amlodipiin |
C09DB07 |
Sandoz Pharmaceuticals d.d. |
|
Fraxiparine - inj lahus süstlis 9500rü anti xa / ml süstel 1ml n2; 1ml n10
|
Nadroparin calcium |
B01AB06 |
Aspen Pharma Trading Limited |
|
Fraxiparine - süstelahus süstlis (2850rü anti xa 0.3ml)
|
kaltsiumnadropariin |
B01AB06 |
Viatris SIA |
|
Fraxiparine - süstelahus süstlis (3800rü anti xa 0.4ml)
|
kaltsiumnadropariin |
B01AB06 |
Viatris SIA |
|
Fraxiparine - süstelahus süstlis (5700rü anti xa 0.6ml)
|
kaltsiumnadropariin |
B01AB06 |
Viatris SIA |
|
Fraxiparine - süstelahus süstlis (7600rü anti xa 0.8ml)
|
kaltsiumnadropariin |
B01AB06 |
Viatris SIA |
|
Froben - suuloputuslahus (2,5mg 1ml)
|
flurbiprofeen |
A01AD91 |
Mylan IRE Healthcare Ltd |
|
Froben - suuõõnesprei, lahus (2,5mg 1ml)
|
flurbiprofeen |
A01AD91 |
Mylan IRE Healthcare Ltd |
|
Fromilid - õhukese polümeerikattega tablett (250mg)
|
klaritromütsiin |
J01FA09 |
KRKA tovarna zdravil d.d. Novo mesto |
|
Fromilid - õhukese polümeerikattega tablett (500mg)
|
klaritromütsiin |
J01FA09 |
KRKA tovarna zdravil d.d. Novo mesto |
|
Fromilid - suukaudse suspensiooni graanulid (125mg 5ml)
|
klaritromütsiin |
J01FA09 |
KRKA tovarna zdravil d.d. Novo mesto |
|
Fromilid - tabl 500mg n14
|
Clarithromycin |
J01FA09 |
KRKA d.d., Novo mesto |
|
Fromilid uno - toimeainet modifitseeritult vabastav tablett (500mg)
|
klaritromütsiin |
J01FA09 |
KRKA tovarna zdravil d.d. Novo mesto |
|
Frondava - nahaemulsioon (1mg 1g)
|
mometasoon |
D07AC13 |
Almirall Hermal GmbH |
|
Frondava - salv 1mg / 1g 10g n1; 15g n1; 20g n1; 25g n1; 30g n1; 35g n1; 50g n1; 60g n1; 70g n1; 90g n1; 100g n1
|
Mometasone |
D07AC13 |
Almirall Hermal GmbH |
|
Frontline combo cats - täpilahus (100mg +120mg 1ml)
|
fiproniil +metopreen |
QP53AX80 |
Merial |
|
Frontline combo dogs - täpilahus (100mg +90mg 1ml)
|
fiproniil +metopreen |
QP53AX80 |
Merial |
|
Frontline spot on - täpilahus (100mg 1ml)
|
fiproniil |
QP53AX15 |
Merial |
|
Frontline spray - nahasprei, lahus (2,5mg 1ml)
|
fiproniil |
QP53AX15 |
Merial SAS |
|
Frovamig
|
– |
– |
– |
|
Fruzaqla
|
frukvintiniib |
L01EK04 |
Takeda Pharmaceuticals International AG Ireland Branch |
|
Ftorocort - salv (0,1%)
|
triamtsinoloon |
D07AB09 |
Gedeon Richter Plc. |
|
Fubelv
|
etanertsept |
L04AB01 |
Biosimilar Collaborations Ireland Limited |
|
Fucicort - kreem (1mg +20mg 1g)
|
beetametasoon +fusidiinhape |
D07CC80 |
LEO Pharma A/S |
|
Fucicort - kreem 1 mg 20mg / g 15g
|
Betamethasone Fusidic acid |
D07CC80 |
LEO Pharma A/S |
|
Fucicort lipid - kreem (1mg +20mg 1g)
|
beetametasoon +fusidiinhape |
D07CC80 |
LEO Pharma A/S |
|
Fucidin
|
– |
– |
– |
|
Fucidin 20 mgg kreem - kreem (20mg 1g)
|
fusidiinhape |
D06AX01 |
LEO Pharma A/S |
|
Fucidin 20 mgg kreem - kreem 20mg / g 15g
|
Fusidic acid |
D06AX01 |
LEO Pharma A/S |
|
Fucidin 20 mgg salv - salv (20mg 1g)
|
fusidiinhape |
D06AX01 |
LEO Pharma A/S |
|
Fucidin 20 mgg salv - salv 20mg / g 15g
|
Fusidic acid |
D06AX01 |
LEO Pharma A/S |
|
Fucidin h - kreem (10mg +20mg 1g)
|
hüdrokortisoon +fusidiinhape |
D07CA83 |
LEO Pharma A/S |
|
Fucidin h - kreem 10mg 20mg / g 15g
|
Hydrocortisone Fusidic acid |
D07CA83 |
LEO Pharma A/S |
|
Fucithalmic - silmatilgad, susp 10mg / 1g 5g n1
|
Fusidic acid |
S01AA13 |
Scandic Pharma SIA |
|
Fucithalmic - silmatilgad, suspensioon (10mg 1g)
|
fusidiinhape |
S01AA13 |
Amdipharm Limited |
|
Fulphila - süstelahus süstlis (6mg 0.6ml)
|
pegfilgrastiim |
L03AA13 |
Biosimilar Collaborations Ireland Limited |
|
Fulvestrant accord - süstelahus süstlis (250mg 5ml)
|
fulvestrant |
L02BA03 |
Accord Healthcare B.V. |
|
Fulvestrant aliud - süstelahus süstlis (250mg 5ml)
|
fulvestrant |
L02BA03 |
Stada Arzneimittel AG |
|
Fulvestrant mylan - süstelahus süstlis (250mg 5ml)
|
fulvestrant |
L02BA03 |
Mylan Pharmaceuticals Limited |
|
Fulvestrant sandoz - süstelahus süstlis (250mg 5ml)
|
fulvestrant |
L02BA03 |
Sandoz Pharmaceuticals d.d. |
|
Fulvestrant stada - süstelahus süstlis (250mg 5ml)
|
fulvestrant |
L02BA03 |
Stada Arzneimittel AG |
|
Fulvestrant teva - süstelahus süstlis (250mg 5ml)
|
fulvestrant |
L02BA03 |
Teva B.V. |
|
Fulvestrant zentiva - süstelahus süstlis (250mg 5ml)
|
fulvestrant |
L02BA03 |
Zentiva k.s. |
|
Furocef - õhukese polümeerikattega tablett (250mg)
|
tsefuroksiim |
J01DC02 |
Krka, d.d., Novo mesto |
|
Furocef - õhukese polümeerikattega tablett (500mg)
|
tsefuroksiim |
J01DC02 |
Krka, d.d., Novo mesto |
|
Furocef - tabl 250mg n10; n12; n14; n16; n20; n24; n15; n8
|
Cefuroxime |
J01DC02 |
Krka, d.d., Novo mesto |
|
Furocef - tabl 500mg n10; n12; n14; n16; n20; n24; n15; n8
|
Cefuroxime |
J01DC02 |
Krka, d.d., Novo mesto |
|
Furogamma 40
|
– |
– |
– |
|
Furosemid nycomed 40 mg - tabl 40mg n100
|
Furosemide |
C03CA01 |
Takeda Pharma AS |
|
Furosemid nycomed 40 mg - tablett (40mg)
|
furosemiid |
C03CA01 |
Takeda Pharma AS |
|
Furosemide accord - süste-/infusioonilahus (10mg 1ml)
|
furosemiid |
C03CA01 |
Accord Healthcare Limited |
|
Furosemide basi - süste-/infusioonilahus (10mg 1ml)
|
furosemiid |
C03CA01 |
Laboratorios Basi Industria Farmaceutica S.A. |
|
Furosemide norameda - süste-/infusioonilahus (10mg 1ml)
|
furosemiid |
C03CA01 |
UAB Norameda |
|
Furosemide teva - tablett (500mg)
|
furosemiid |
C03CA01 |
Teva Pharma B.V. |
|
Furosoral vet - tablett (10mg)
|
furosemiid |
QC03CA01 |
Le Vet. Beheer B.V. |
|
Furosoral vet - tablett (40mg)
|
furosemiid |
QC03CA01 |
Le Vet. Beheer B.V. |
|
Futura ginkgo biloba
|
– |
– |
– |
|
Fuzeon
|
enfuvirtiid |
J05AX07 |
Roche Registration Ltd. |
|
Fycompa
|
perampanel |
N03AX22 |
Eisai GmbH |
|
Fylrevy
|
estetrool |
G03CA10 |
Gedeon Richter Plc. |
|
Fymskina
|
ustekinumab |
L04AC05 |
Formycon AG |
|
Fypryst - nahasprei, lahus (2,5mg 1ml)
|
fiproniil |
QP53AX15 |
KRKA d.d., Novo mesto |
|
Fypryst - täpilahus (134mg 1.34ml)
|
fiproniil |
QP53AX15 |
KRKA d.d., Novo mesto |
|
Fypryst - täpilahus (268mg 2.68ml)
|
fiproniil |
QP53AX15 |
KRKA d.d., Novo mesto |
|
Fypryst - täpilahus (402mg 4.02ml)
|
fiproniil |
QP53AX15 |
KRKA d.d., Novo mesto |
|
Fypryst - täpilahus (50mg 0.5ml)
|
fiproniil |
QP53AX15 |
KRKA d.d., Novo mesto |
|
Fypryst - täpilahus (67mg 0.67ml)
|
fiproniil |
QP53AX15 |
KRKA d.d., Novo mesto |
|
Fypryst combo - täpilahus (134mg +120,6mg 1.34ml)
|
fiproniil +metopreen |
QP53AX80 |
KRKA d.d., Novo mesto |
|
Fypryst combo - täpilahus (268mg +241,2mg 2.68ml)
|
fiproniil +metopreen |
QP53AX80 |
KRKA d.d., Novo mesto |
|
Fypryst combo - täpilahus (402mg +361,8mg 4.02ml)
|
fiproniil +metopreen |
QP53AX80 |
KRKA d.d., Novo mesto |
|
Fypryst combo - täpilahus (50mg +60mg 0.5ml)
|
fiproniil +metopreen |
QP53AX80 |
KRKA d.d., Novo mesto |
|
Fypryst combo - täpilahus (67mg +60,3mg 0.67ml)
|
fiproniil +metopreen |
QP53AX80 |
KRKA d.d., Novo mesto |
